ULTRAGENYX PHARMACEUTICAL INC. Other Nonoperating Income (Expense)
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Other Nonoperating Income (Expense) of $1.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-05
- ULTRAGENYX PHARMACEUTICAL INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was $1.00M, a 50.00% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$934.00K.
- ULTRAGENYX PHARMACEUTICAL INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$1.04M, a 133.90% decline year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. other nonoperating income (expense) for the quarter ending 2025-06-30 was $2.00M.
- ULTRAGENYX PHARMACEUTICAL INC. other nonoperating income (expense) for fiscal 2025 was $1.00M.
- ULTRAGENYX PHARMACEUTICAL INC. other nonoperating income (expense) for fiscal 2024 was -$5.00M.
- ULTRAGENYX PHARMACEUTICAL INC. other nonoperating income (expense) for fiscal 2023 was -$1.00M.
- ULTRAGENYX PHARMACEUTICAL INC. other nonoperating income (expense) for fiscal 2022 was -$1.57M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed | Other Nonoperating Income (Expense) 47 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-05 | $1.00M 10-Q · filed 2026-08-05 | ||||||
| 2025-12-31 | -$934.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$1.98M derived: sum of 2 quarters · filed 2026-02-18 | $23.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.00M 10-K · filed 2026-02-18 | ||||
| 2025-09-30 | -$1.04M 10-Q · filed 2025-11-05 | $957.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.93M 10-Q · filed 2025-11-05 | -$2.85M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $2.00M 10-Q · filed 2026-08-05 | $2.14M 10-Q · filed 2025-08-06 | $2.00M 10-Q · filed 2026-08-05 | $2.98M 10-Q · filed 2025-08-06 | -$1.81M derived: sum of 3 quarters · filed 2026-08-05 | $1.27M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $837.00K 10-Q · filed 2025-05-07 | -$3.81M derived: sum of 2 quarters · filed 2026-02-18 | -$729.00K derived: sum of 3 quarters · filed 2026-02-18 | -$2.56M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-12-31 | -$4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | -$1.57M derived: sum of 2 quarters · filed 2026-02-18 | -$3.40M derived: sum of 3 quarters · filed 2026-02-18 | -$5.00M 10-K · filed 2026-02-18 | -$3.96M 10-K · filed 2025-02-19 | |||
| 2024-09-30 | $3.08M 10-Q · filed 2025-11-05 | $1.25M derived: sum of 2 quarters · filed 2025-11-05 | -$357.00K 10-Q · filed 2025-11-05 | $1.02M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-06-30 | -$1.83M 10-Q · filed 2025-08-06 | -$3.43M 10-Q · filed 2025-08-06 | -$2.05M derived: sum of 3 quarters · filed 2026-02-18 | -$2.75M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-03-31 | -$1.60M 10-Q · filed 2025-05-07 | -$225.00K derived: sum of 2 quarters · filed 2026-02-18 | -$924.00K derived: sum of 3 quarters · filed 2026-02-18 | -$2.91M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2023-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $681.00K derived: sum of 2 quarters · filed 2026-02-18 | -$1.31M derived: sum of 3 quarters · filed 2026-02-18 | -$1.00M 10-K · filed 2026-02-18 | -$337.00K 10-K · filed 2024-02-21 | |||
| 2023-09-30 | -$699.00K 10-Q · filed 2024-11-06 | -$2.69M derived: sum of 2 quarters · filed 2024-11-06 | -$2.38M 10-Q · filed 2024-11-06 | -$2.20M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-06-30 | -$1.99M 10-Q · filed 2024-08-02 | -$1.68M 10-Q · filed 2024-08-02 | -$1.50M derived: sum of 3 quarters · filed 2025-02-19 | -$2.61M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-03-31 | $308.00K 10-Q · filed 2024-05-03 | $488.00K derived: sum of 2 quarters · filed 2025-02-19 | -$617.00K derived: sum of 3 quarters · filed 2025-02-19 | -$1.55M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | $180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$925.00K derived: sum of 2 quarters · filed 2025-02-19 | -$1.85M derived: sum of 3 quarters · filed 2025-02-19 | -$1.57M 10-K · filed 2025-02-19 | ||||
| 2022-09-30 | -$1.10M 10-Q · filed 2023-11-03 | -$2.04M derived: sum of 2 quarters · filed 2023-11-03 | -$1.75M 10-Q · filed 2023-11-03 | -$2.16M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | -$930.00K 10-Q · filed 2023-08-04 | -$641.00K 10-Q · filed 2023-08-04 | -$1.05M derived: sum of 3 quarters · filed 2024-02-21 | -$1.47M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | $289.00K 10-Q · filed 2023-05-05 | -$121.00K derived: sum of 2 quarters · filed 2024-02-21 | -$536.00K derived: sum of 3 quarters · filed 2024-02-21 | -$603.00K derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | -$410.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$825.00K derived: sum of 2 quarters · filed 2024-02-21 | -$892.00K derived: sum of 3 quarters · filed 2024-02-21 | -$1.69M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | -$415.00K 10-Q · filed 2022-11-03 | -$482.00K derived: sum of 2 quarters · filed 2022-11-03 | -$1.28M 10-Q · filed 2022-11-03 | -$978.00K derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-06-30 | -$67.00K 10-Q · filed 2022-07-29 | -$862.00K 10-Q · filed 2022-07-29 | -$563.00K derived: sum of 3 quarters · filed 2023-02-17 | -$16.00K derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-03-31 | -$795.00K 10-Q · filed 2022-05-06 | -$496.00K derived: sum of 2 quarters · filed 2023-02-17 | $51.00K derived: sum of 3 quarters · filed 2023-02-17 | $268.00K derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2020-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $846.00K derived: sum of 2 quarters · filed 2023-02-17 | $1.06M derived: sum of 3 quarters · filed 2023-02-17 | $607.00K 10-K · filed 2023-02-17 | ||||
| 2020-09-30 | $547.00K 10-Q · filed 2021-11-03 | $764.00K derived: sum of 2 quarters · filed 2021-11-03 | $308.00K 10-Q · filed 2021-11-03 | $462.00K derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2020-06-30 | $217.00K 10-Q · filed 2021-08-03 | -$239.00K 10-Q · filed 2021-08-03 | -$85.00K derived: sum of 3 quarters · filed 2022-02-15 | -$238.00K derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2020-03-31 | -$456.00K 10-Q · filed 2021-05-05 | -$302.00K derived: sum of 2 quarters · filed 2022-02-15 | -$455.00K derived: sum of 3 quarters · filed 2022-02-15 | -$831.00K derived: sum of 4 quarters · filed 2022-02-15 | ||||
| 2019-12-31 | $154.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.00K derived: sum of 2 quarters · filed 2022-02-15 | -$375.00K derived: sum of 3 quarters · filed 2022-02-15 | -$787.00K 10-K · filed 2022-02-15 | ||||
| 2019-09-30 | -$153.00K 10-Q · filed 2020-10-27 | -$529.00K derived: sum of 2 quarters · filed 2020-10-27 | -$941.00K 10-Q · filed 2020-10-27 | -$928.00K derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-06-30 | -$376.00K 10-Q · filed 2020-07-30 | -$788.00K 10-Q · filed 2020-07-30 | -$775.00K derived: sum of 3 quarters · filed 2021-02-12 | -$922.00K derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2019-03-31 | -$412.00K 10-Q · filed 2020-05-07 | -$399.00K derived: sum of 2 quarters · filed 2021-02-12 | -$546.00K derived: sum of 3 quarters · filed 2021-02-12 | -$1.04M derived: sum of 4 quarters · filed 2021-02-12 | ||||
| 2018-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$134.00K derived: sum of 2 quarters · filed 2021-02-12 | -$630.00K derived: sum of 3 quarters · filed 2021-02-12 | -$5.59M 10-K · filed 2021-02-12 | ||||
| 2018-09-30 | -$147.00K 10-Q · filed 2019-11-06 | -$643.00K derived: sum of 2 quarters · filed 2019-11-06 | -$5.60M 10-Q · filed 2019-11-06 | -$7.44M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | -$496.00K 10-Q · filed 2019-08-02 | -$5.45M 10-Q · filed 2019-08-02 | -$7.29M derived: sum of 3 quarters · filed 2020-02-14 | -$3.92M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | -$4.96M 10-Q · filed 2019-05-07 | -$6.80M derived: sum of 2 quarters · filed 2020-02-14 | -$3.42M derived: sum of 3 quarters · filed 2020-02-14 | $990.00K derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2017-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $1.53M derived: sum of 2 quarters · filed 2020-02-14 | $5.95M derived: sum of 3 quarters · filed 2020-02-14 | $6.53M 10-K · filed 2020-02-14 | ||||
| 2017-09-30 | $3.37M 10-Q · filed 2018-11-06 | $7.79M derived: sum of 2 quarters · filed 2018-11-06 | $8.37M 10-Q · filed 2018-11-06 | $6.75M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $4.41M 10-Q · filed 2018-08-03 | $5.00M 10-Q · filed 2018-08-03 | $3.38M derived: sum of 3 quarters · filed 2019-02-20 | $3.33M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $582.00K 10-Q · filed 2018-05-08 | -$1.03M derived: sum of 2 quarters · filed 2019-02-20 | -$1.08M derived: sum of 3 quarters · filed 2019-02-20 | -$920.00K derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$1.66M derived: sum of 2 quarters · filed 2019-02-20 | -$1.50M derived: sum of 3 quarters · filed 2019-02-20 | -$1.62M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | -$46.00K 10-Q · filed 2017-11-03 | $113.00K derived: sum of 2 quarters · filed 2017-11-03 | -$6.00K 10-Q · filed 2017-11-03 | $14.00K derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $159.00K 10-Q · filed 2017-07-28 | $40.00K 10-Q · filed 2017-07-28 | $60.00K derived: sum of 3 quarters · filed 2018-02-21 | $91.00K derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | -$119.00K 10-Q · filed 2017-05-05 | -$99.00K derived: sum of 2 quarters · filed 2018-02-21 | -$68.00K derived: sum of 3 quarters · filed 2018-02-21 | -$169.00K derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $51.00K derived: sum of 2 quarters · filed 2018-02-21 | -$50.00K derived: sum of 3 quarters · filed 2018-02-21 | -$200.00K 10-K · filed 2018-02-21 | ||||
| 2015-09-30 | $31.00K 10-Q · filed 2016-11-08 | -$70.00K derived: sum of 2 quarters · filed 2016-11-08 | -$220.00K 10-Q · filed 2016-11-08 | -$210.00K derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | -$101.00K 10-Q · filed 2016-08-09 | -$251.00K 10-Q · filed 2016-08-09 | -$241.00K derived: sum of 3 quarters · filed 2017-02-17 | -$426.00K derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | -$150.00K 10-Q · filed 2016-05-10 | -$140.00K derived: sum of 2 quarters · filed 2017-02-17 | -$325.00K derived: sum of 3 quarters · filed 2017-02-17 | -$398.00K derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$175.00K derived: sum of 2 quarters · filed 2017-02-17 | -$248.00K derived: sum of 3 quarters · filed 2017-02-17 | -$3.63M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | -$185.00K 10-Q · filed 2015-11-10 | -$258.00K derived: sum of 2 quarters · filed 2015-11-10 | -$3.64M 10-Q · filed 2015-11-10 | -$5.49M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | -$73.00K 10-Q · filed 2015-08-14 | $76.00K 10-Q · filed 2014-08-11 | -$3.46M 10-Q · filed 2015-08-14 | -$3.21M 10-Q · filed 2014-08-11 | -$5.31M derived: sum of 3 quarters · filed 2016-02-26 | -$6.04M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-03-31 | -$3.38M 10-Q · filed 2015-05-12 | -$3.29M 10-Q · filed 2014-05-12 | -$5.24M derived: sum of 2 quarters · filed 2016-02-26 | -$5.97M derived: sum of 3 quarters · filed 2016-02-26 | -$6.31M derived: sum of 4 quarters · filed 2016-02-26 | -$6.77M 10-Q · filed 2014-05-12 | ||
| 2013-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$2.59M derived: sum of 2 quarters · filed 2016-02-26 | -$2.93M derived: sum of 3 quarters · filed 2016-02-26 | -$3.01M 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | -$735.00K 10-Q · filed 2014-11-10 | -$1.08M derived: sum of 2 quarters · filed 2014-11-10 | -$1.16M 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | -$343.00K 10-Q · filed 2014-08-11 | -$331.00K 10-Q · filed 2014-08-11 | ||||||
| 2013-03-31 | $12.00K 10-Q · filed 2014-05-12 | |||||||
| 2012-12-31 | -$350.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |